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Elderly HIV-infected patients may present particularities
on both disease evolution and morbidity, as compared
to younger patients. Moreover, elderly patients are more
likely to take numerous medications due to their age-
related condition. VISAGE is a French multidisciplinary
study group focusing on elderly HIV-infected patients in
order to evaluate and improve their therapeutic care.
Our study “Visage 1” aimed to analyse potential drug
interactions between antiretroviral drugs (ARV) and all
other products taken by elderly HIV-infected patients.
This 6-month prospective study involved patients trea-
ted for HIV infection and aging more than sixty years at
the time of the study. Patients were to fill an anon-
ymous self-questionnaire for reporting their ARV, dis-
eases other than HIV infection, and drugs or products
regularly taken other than ARV. Observance has been
evaluated using a visual analog scale graduated on 10.
Analysis of drug interactions relied on the French drug
agency (Afssaps) thesaurus by using the tool available
on the website www.theriaque.org.
25 women and 70 men filled 95 questionnaires. Median
age was 65.3±5.2 years. Treatment of HIV infection was a
combination of three ARV for 85% of patients. Among
patients, 94% had concomitant treatment with non-ARV
drugs (4.6 ± 3.3 drugs /patient) mainly prescribed for a
cardiovascular mean. Most frequently used concomitant
drugs were paracetamol, lysine acetyl salicylate, bromaze-
pam, rosuvastatin, and zolpidem. Other products widely
used were sexual stimulants and vitamins. Consumption
of alcohol, poppers and cannabis occurred in 40, 3, and 2
patients, respectively. Clinically relevant drug interaction
occurred in 45% of prescriptions and involved non-ARV
drugs but were not in majority classified as serious. Two
associations were found contra-indicated: ritonavir+alfu-
sozine and protease inhibitor+simvastatin. Observance
reached 9.9 ± 0.4 for antiretroviral drugs, and 9.8 ± 0.6
for the other drugs.
Drug interactions were less frequent and less severe than
expected in this population. Physicians’ awareness of con-
comitant drugs taken by the patient is crucial since most
clinically and severe interactions occurred between ARV
and non-ARV drugs. Observance was extremely high as
compared with the rate usually described for the general
population of HIV-infected patients and reasons of that
high rate need to be further investigated.
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